pharmacie et médicaments – Traitement pris par les personnes atteintes du syndrome Smith Magenis

This written question concerns the treatment of individuals with Smith-Magenis Syndrome, a rare genetic disorder. It seeks information on the medical approaches and therapies currently available or under consideration for managing the condition. The question is directed towards understanding the current state of pharmaceutical interventions and patient care for those affected by this syndrome, potentially impacting patients and healthcare providers.